skip navigation Smaller text size Reset text size Larger text size
Families & Children Women Teens Adults Seniors People with Disabilities

September is Newborn Screening Awareness Month!

Newborn Screening matters to expecting parents, new parents, grandparents, sisters, brothers, healthcare providers, nurses and everyone in between.

Each year there are nearly 4 million babies born in the United States, and while most of them are born healthy, some infants are born with serious but treatable medical conditions. Newborn Screening helps healthcare providers to identify and treat these conditions before the infant becomes ill.

We encourage you to join us in raising awareness for Newborn Screening. Learn more at



BabyThe Newborn Screening Program is responsible for assuring that all infants born in New Hampshire are screened at birth for inherited disorders. A few drops of blood are taken from an infant's heel 24-48 hours after birth. This is in accordance with state legislation (RSA 132:10a). Families may refuse this screening if they wish. The goal of this screening is early identification of these conditions so that timely treatment and intervention can take place. If disorders are untreated, some of these conditions can cause death and disability. New Hampshire has a Newborn Screening Advisory Committee that makes recommendations to the state program on clinical, educational or operational aspects of the program. The Newborn Screening Advisory Committee (NBSAC) in a non-pandemic time would meet on a bi-annual basis, also in accordance with RSA 132:10-a and Administrative Rule He-P 3008. Meetings are to resume on a bi-annual basis, and will be held twice yearly, in May and October.

The Newborn Screening Program is responsible for handling screening results and follow-up of out-of-range results, as needed. Parents are encouraged to ask their health care provider about the newborn screening results at their baby's two-week office visit.

Critical Congenital Heart Defects (CCHD)

Babies born with a Critical Congenital Heart Defect (CCHD) are at significant risk for disability or death if not diagnosed soon after birth. Law in New Hampshire requires CCHD screening by birth hospitals, midwives and birth attendants. Per RSA 132:10aa and RSA 141 J and Administrative rules, He-P 3008 He-P 3012 it is now required that birth facilities report CCHD, hearing screening results, and birth conditions known at birth to the Maternal and Child Health Section. For more information on CCHD visit Newborn Pulse Oximetry Screening to Detect Critical Congenital Heart Disease at

Fact Sheets

Health Care Providers

Parents – English

Parents – Spanish

Screening Panel

The screening panel includes screening for the following conditions:

  1. Argininemia (ARG)
  2. Argininosuccinic Academia (ASA)
  3. Biotinidase Deficiency (BIOT)
  4. Carnitine Uptake Defect (CUD)
  5. Carnitine Palmitoyltransferase II Deficiency (CPT II)
  6. Citrullinemia (CIT)
  7. Cobalamin A, B (Cbl A, B)
  8. Congenital Adrenal Hyperplasia (CAH)
  9. Congenital Hypothyroidism (CH)
  10. Congenital Toxoplasmosis (TOXO)
  11. Critical Congenital Heart Disorder (CCHD)
  12. Cystic Fibrosis (CF)
  13. Galactosemia (GALT)
  14. Glutaric Academia Type I (GAI)
  15. Hemoglobinopathies (Hb S/βTh), (Hb S/C), (Hb SS)
  16. 3-hydroxy-3-methyl gluteric aciduria (HMG)
  17. Hyperornithinemia Hyperammoninemia, Homocitrullinemia Syndrome (HHH)
  18. Homocystinuria (HCY)
  19. Isovaleric Academia (IVA)
  20. Long-chain L-3-OH Acyl-CoA Dehydrogenase Deficiency (LCHAD)
  21. Maple Syrup Urine Disease (MSUD)
  22. Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCAD)
  23. 3-Methylcrotonyl-CoA Carboxylase Deficiency(3MCC)
  24. Methylmalonic Academia: Mutase Deficiency (MUT)
  25. Mitochondrial Acetoacetyl-CoA Thiolase Deficiency (BKT)
  26. Mucopolysaccharidosis Type 1 (MPS1)
  27. Multiple Acyl-CoA Dehydrogenase Deficiency (GA2)
  28. Multiple Carboxylase Deficiency (MCD)
  29. Pompe Disease (POMPE)
  30. Propionic Academia (PROP)
  31. Phenylketonuria (PKU)
  32. Severe Combined Immunodeficiency (SCID)
  33. Spinal Muscular Atrophy (SMA)
  34. Trifunctional Protein Deficiency (TFP)
  35. Tyrosinemia Type 1 (TYR 1)
  36. Very Long-chain Acyl-CoA Dehydrogenase Deficiency (VLCAD)
  37. X-Linked Adrenoleukodystrophy (X-ALD)

Adobe Acrobat Reader Symbol Adobe Acrobat Reader format. You can download a free reader from Adobe.

Translate this page


New Hampshire Department of Health and Human Services
129 Pleasant Street | Concord, NH | 03301-3852

copyright 2016. State of New Hampshire